Skip to main content
Figure 3 | BMC Pulmonary Medicine

Figure 3

From: Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from Cystic Fibrosis patients during intravenous antibiotic treatment

Figure 3

Differences in inflammatory markers in healthy controls and CF patients, before and during i.v. antibiotic therapy. Matrixmetalloproteinase 9 (MMP9) was clearly attenuated during therapy (A). RANTES levels declined under AB treatment (B). IL-6 was found to be significantly elevated in CF (C), declining during antibiotic treatment in almost all CF patients (D).

Back to article page